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Background. The base rate of transition from subthreshold psychotic experiences (the exposure) to clinical psychotic
disorder (the outcome) in unselected, representative and non-help-seeking population-based samples is unknown.
Method. A systematic review and meta-analysis was conducted of representative, longitudinal population-based
cohorts with baseline assessment of subthreshold psychotic experiences and follow-up assessment of psychotic and
non-psychotic clinical outcomes.
Results. Six cohorts were identified with a 3–24-year follow-up of baseline subthreshold self-reported psychotic
experiences. The yearly risk of conversion to a clinical psychotic outcome in exposed individuals (0.56%) was 3.5
times higher than for individuals without psychotic experiences (0.16%) and there was meta-analytic evidence of
dose–response with severity/persistence of psychotic experiences. Individual studies also suggest a role for
motivational impairment and social dysfunction. The evidence for conversion to non-psychotic outcome was weaker,
although findings were similar in direction.
Conclusions. Subthreshold self-reported psychotic experiences in epidemiological non-help-seeking samples index
psychometric risk for psychotic disorder, with strong modifier effects of severity/persistence. These data can serve as
the population reference for selected and variable samples of help-seeking individuals at ultra-high risk, for whom
much higher transition rates have been indicated.
Received 2 August 2011 ; Revised 18 November 2011 ; Accepted 28 November 2011
Key words : Delusions, hallucinations, meta-analysis, prevention, psychotic disorders, risk.
Introduction
Psychotic experiences are common in the general
population (van Os et al. 2009). A systematic review of
285 rates of prevalence or incidence of psychotic ex-
periences showed that half of the considerable het-
erogeneity in rates of subclinical psychotic experiences
across studies is due to study cohort and design fac-
tors (Linscott & van Os, 2010). In particular, rates were
found to be higher in studies using smaller sample
sizes, convenience sampling and self-report assess-
ment.
A major and hitherto unresolved issue is that
the base risk of conversion to clinical disorder, given
earlier expression of subclinical psychotic experiences
in unselected, representative and non-help-seeking
general population samples, remains unknown.
Assessment of the risk is important because it can
serve as the population reference against which re-
ported risk of conversion from ‘ultra-high’ risk status
to psychotic disorder in variable and highly selected
samples can be compared. To address this issue,
we reviewed the literature on the risk of developing
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psychotic disorder given earlier expression of sub-
clinical psychotic experiences in non-service-using
representative population samples. To this end, the
method of systematic review and meta-analysis
was used, as these generally provide a transparent
and quantitative approach to identify, summarize
and critically appraise relevant studies, enabling
an integrated presentation of results. Furthermore,
systematic review and meta-analysis can address
meta-hypotheses over and above primary studies by
quantitative exploration of the patterns of results
from single investigations. Specific aims of the meta-
analysis were : (i) to examine the risk of conversion to
psychotic disorder given the presence of subclinical
psychotic experiences in representative general popu-
lation samples, (ii) to examine the risk of conversion
to non-psychotic disorder given the presence of sub-
clinical psychotic experiences in representative gen-
eral population samples, and (iii) to examine which
factors moderate risk of conversion. To achieve
these goals, the methodology for systematic review as
described in Meta-analysis of Observational Studies
in Epidemiology (MOOSE) guidelines (Stroup et al.
2000) was applied. For some studies, additional
analyses were conducted in the original data so that
non-psychotic outcomes that had not been included in
the original publications could also be reported.
Method
To reduce methodological variation of studies to
be entered in the meta-analysis, a priori criteria for
inclusion were formulated. Thus, data of published
studies were added to the meta-analysis database if
they (i) were published in a peer-reviewed journal
after 1950 ; (ii) were written using the English, Spanish,
French, German or Dutch language; (iii) represented
a population-based or comparably representative
follow-up study of individuals with and without a
defined measure of subclinical psychotic experiences
at baseline (the ‘exposure ’) ; and (iv) provided cumu-
lative incidence rates (or data allowing computation
of these) of defined psychotic disorder outcomes
(the ‘outcome’).
A computerized search strategy was developed to
sensitively query the MEDLINE, PsycINFO and
EMBASE databases to identify potentially relevant
articles in English, Spanish, German, French or Dutch,
published from 1951 to April 2010. A sensitive search
string was compiled, based on three elements. The
first was defined as : (((psychosis OR psychotic)
AND (subthreshold OR subclinical OR non-clinical))
OR psychosis-like OR psychotic-like OR schizotypy
OR ‘psychotic experience* ’ OR ‘psychotic symptom*’
OR ‘psychosis proneness ’ OR hallucinat* OR
delusion* OR hallucination-like OR delusion-like
OR delusional-like) ; this was combined (‘AND’) with
a second search element of (follow-up OR transition
OR conversion OR longitudinal OR incidence OR
predict* OR ‘cohort study’) while excluding (‘NOT’),
in the third search element (mice ORmouse OR rat OR
dementia OR Parkinson’s OR Lewy body OR cancer
OR aids). This yielded over 3000 citations. Two in-
vestigators independently screened citations and
selected publications for further consideration on
the basis of consensus, using three consecutive filters.
The first selection filter was at the level of citations,
applying the broad criterion of relevance for the topic
of the meta-analysis. The second selection filter was
applied at the level of abstracts, excluding studies that
did not meet a single inclusion criterion as defined
above. The final filter was based on inspection of full-
text articles. In the case of multiple reports involving
a single study population, the publication with the
largest sample size and/or the longest follow-up
was selected. The great majority of studies identified
in the initial search were rejected because (i) reports
were on patients with established psychotic disorder
or other disorders, or on non-representative, non-
epidemiological samples of help-seeking individuals
meeting ultra-high risk criteria, (ii) samples included
cross-sectional data only or (iii) follow-up measures
did not include a defined clinical outcome. Five
studies (Chapman et al. 1994; Poulton et al. 2000 ;
Hanssen et al. 2005 ; Welham et al. 2009 ; Dominguez
et al. 2011) thus remained that after full inspection
were deemed suitable for inclusion. Reference lists of
these articles were screened to encounter additional
articles (yielding no additional citations). In addition,
a process of forward and backward citation tracking
was executed using the Web of Science database
(yielding no additional citations). Finally, researchers
with expertise in the field were contacted to identify
additional publications and/or data potentially
relevant for the meta-analysis. This resulted in the
following additional data. First, original individual
participant data from two cohort studies, the
Netherlands Mental Health Survey and Incidence
Study (NEMESIS ; Bijl et al. 1998a, b) and the Early
Developmental Stages of Psychopathology (EDSP)
study (Wittchen et al. 1998 ; Lieb et al. 2000), were
subjected to additional analyses to add information
on non-psychotic outcomes, not published before,
to the meta-analysis database. Second, one additional
study (Werbeloff et al. 2012) was identified that was
suitable for inclusion in the meta-analysis.
In the next step, two investigators independently
extracted quantitative and qualitative data from the
six selected publications. A priori qualitative data in-
cluded factors impacting on internal validity, such
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as methodological and design features, in addition to
the potential for confounding and also bias due to
differential attrition or possible differential assessment
of exposure and/or outcome. None of the six ident-
ified studies were excluded on the basis of these con-
siderations. Quantitative data included cumulative
conversion rates as a function of baseline exposure
status (i.e. with and without subclinical psychotic ex-
periences). Data pertaining to studies using continu-
ous exposure measures were extracted and analysed
according to the original continuous exposure format,
and additionally analysed as a dichotomous exposure
to facilitate comparison of results across studies.
Dichotomization was carried out by contrasting, in the
case of three-level exposure variables (e.g. no symp-
toms, weak symptom, strong symptom), the highest
category versus the lowest two. In the case of four-
level exposures, the highest category was similarly
compared to the lowest three. If data could not be
extracted in a format suitable for meta-analysis, the
authors were contacted for reanalysis of the original
data in the required format.
Table 1a was compiled to provide a descriptive
summary of selected studies, showing, for both psy-
chotic and non-psychotic outcomes, the principal
study characteristics including populations, obser-
vation periods, exposure and outcome definitions,
main results and sample and study design features.
Tables 1b and 1c show the quantitative data extracted
from each study for psychotic and non-psychotic out-
comes respectively.
Approach to meta-analysis
Data from the selected studies were combined to esti-
mate pooled rates with their corresponding 95% con-
fidence intervals (CIs) under a random effects model,
assuming that true effects were randomly distributed
around the mean effect size. The random effect model
presumes that variation in samples and design factors
will occasion different true effect sizes across studies
and represented a valid a priori choice, given that
methods and populations across studies did not cor-
respond to a degree that they could be regarded as
estimating the same underlying effect. The between-
study variance in the random effects model reflects
heterogeneity across studies, the magnitude of which
was evaluated using a x2 test for heterogeneity, testing
whether individual studies varied more than could be
explained by chance alone. In the phase of reading and
comparing the articles, various hypotheses for het-
erogeneity were identified.
Additional analyses undertaken in original datasets
For the specific purpose of the meta-analysis, exposure
and outcome data as reported in the NEMESIS by
Hanssen et al. (2005) and in the EDSP study by
Dominguez et al. (2011) were subjected to additional
analyses. Both the NEMESIS and the EDSP study
followed general population cohorts, interviewing
the entire cohort with the Composite International
Diagnostic Interview (CIDI) on three occasions
(NEMESIS : T0, T1 and T2; EDSP: T0, T2 and T3) over
time (Bijl et al. 1998a, b ; Wittchen et al. 1998 ; Lieb et al.
2000). In the NEMESIS, fresh analyses were conducted
to provide additional risk estimates for prevalent ex-
posure [defined as lifetime report of subclinical psy-
chotic experiences at T0, as described in van Os et al.
(2000)], in addition to the incident exposure reported
in the original paper (Hanssen et al. 2005). In both the
NEMESIS and the EDSP data sets, additional analyses
were conducted with the following non-psychotic
outcomes : T2 (NEMESIS) or T3 (EDSP) CIDI diagnosis
of bipolar disorder, excluding individuals with a
similar diagnosis at T0/T1 (NEMESIS) or T0/T2
(EDSP) (Regeer et al. 2006, 2009 ; Tijssen et al. 2010a, b) ;
T2 (NEMESIS) or T3 (EDSP) CIDI diagnosis of de-
pressive disorder, excluding individuals with a simi-
lar diagnosis at T0/T1 (NEMESIS) or T0/T2 (EDSP)
and individuals with a T2 (NEMESIS) or T3 (EDSP)
CIDI diagnosis of bipolar disorder (Regeer et al. 2006,
2009 ; Tijssen et al. 2010a, b) ; and T2 (NEMESIS) or T3
(EDSP) CIDI diagnosis of anxiety disorder, excluding
individuals with a similar diagnosis at T0/T1
(NEMESIS) or T0/T2 (EDSP) and also individuals
with a T2 (NEMESIS) or T3 (EDSP) CIDI diagnosis of
depressive disorder or bipolar disorder (Bijl et al.
1998a, b ; Zimmermann et al. 2003). All extra analyses
were conducted in strict accordance with the meth-
odology described in the original studies and are
therefore not reported again in detail here (details
available upon request).
Statistical analysis
All analyses were performed using Stata 11
(StataCorp, 2009). A data file including data pertaining
to both psychotic and non-psychotic outcomes was
constructed. One study reported five different psy-
chotic outcomes (Chapman et al. 1994) ; these were
combined into a single psychotic outcome.
First, dichotomized exposures were analysed.
For these analyses, each record in the data included
sample size, number of subjects with a particular out-
come, years of study follow-up and information on
modifiers. Using the first three variables, rates per
100 000 person-years were calculated. For each study,
at least two records were filled (exposed, non-ex-
posed). More records were used when rates were
stratified by possible outcome modifiers (psychotic/
non-psychotic disorder, hospital admission yes/no,
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incident/prevalent exposure). Bar charts were gener-
ated to present the rates per study for psychotic and
also for non-psychotic outcomes (Saha et al. 2008 ;
Linscott & van Os, 2010).
A meta-analysis stratified by exposure and by type
of outcome (psychotic/non-psychotic) generated
forest plots (Stata METAN command). Subsequently, the
rates were analysed using meta-regression analysis
(Stata METAREG command). As rates are not normally
distributed, and the number of studies was small
and heterogeneity was expected, meta-regression was
repeated using 1000 permutations (Stata METAREG
command with option PERMUTE). In addition, meta-
regression analyses were repeated for more homo-
geneous subsets of studies (as described below).
Second, to study dose–response effects, exposures
were analysed as three-level variables including three
categories of graded severity/frequency where avail-
able ; if there were four categories, the two lowest cat-
egories were combined to create a similar three-level
exposure variable. For this analysis, rates were also
presented in a figure andmeta-regression analysis was
performed.
The study by Chapman et al. (1994) was carried out
in a sample of students and not in the general popu-
lation. In addition, there was one study that can be
considered an outlier with respect to outcome assess-
ment (hospital admission) (Werbeloff et al. 2012).
Therefore, a planned sensitivity analysis was carried
out excluding these studies, focusing on the four
studies that used comparable CIDI-based method-
ology (Poulton et al. 2000 ; Hanssen et al. 2005 ; Welham
et al. 2009 ; Dominguez et al. 2010).
Results
Search results
The search yielded seven articles with data that were
pertinent to the meta-analysis as specified in the cri-
teria above. One study (Kwapil et al. 1997) was ex-
cluded as it concerned a subgroup of persons included
in the study by Chapman et al. (1994), already in-
cluded in the meta-analysis.
The characteristics of the six studies included in
the meta-analysis are listed in Table 1a. Most studies
had general population sampling frames (two birth
cohorts : (Poulton et al. 2000 ; Welham et al. 2009) ; three
representative general population cohorts (Hanssen
et al. 2005 ; Dominguez et al. 2011; Werbeloff et al.
2012) and one study presented a representative sam-
ple of undergraduate students (Chapman et al. 1994) ;
follow-up varied from 3 to 24 years. All studies re-
ported on variably defined self-reported psychotic
experiences in the general population and the rate ofD
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m
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ez
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transition to variably defined psychotic and non-
psychotic clinical outcomes. One study used high
level of schizotypy as predictor (Chapman et al. 1994) ;
all other studies used CIDI or related measures of
subthreshold psychotic experiences. Non-psychotic
outcomes were depression, mania, anxiety disorder
and admission to hospital for non-psychotic disorder.
Some studies described various exposure subgroups,
including classification on the basis of number of
symptoms (no symptom, single symptom, multiple
symptoms) ; frequency/certainty of psychotic symp-
toms (no symptom, ‘weak’ symptom and ‘strong’
symptom) ; psychopathological context (no symptom,
symptom without depression, symptom with
depression) ; and degree of persistence over 5 years
(present at none, one, two or three assessments over
5 years). Some studies also described rates as a func-
tion of combinations of subgroups (e.g. multiple
symptoms with and without co-morbid depression;
Hanssen et al. 2005). All six studies reported on psy-
chotic clinical outcomes, and five studies additionally
reported on other, non-psychotic, clinical outcomes.
For one study (Hanssen et al. 2005), measures of both
incident (psychotic experiences with first onset in
the previous year) and prevalent (lifetime presence
of psychotic experiences) exposure were available.
One study (Werbeloff et al. 2012) reported service-
based clinical outcome, defined as admission to hos-
pital. All study populations were from developed
nations including The Netherlands, Germany, Israel,
Australia, New Zealand and the USA.
Description of the possible modifiers as causes of
heterogeneity of the studies
Four studies (Poulton et al. 2000 ; Hanssen et al. 2005 ;
Welham et al. 2009 ; Dominguez et al. 2011) used
similar methodology for exposure and outcome as-
sessment based on the CIDI (Robins et al. 1988)
whereas other studies (Chapman et al. 1994 ; Werbeloff
et al. 2012) used different instruments. Similarly, all
studies reported exposure assessment based on
prevalence estimates whereas one study also reported
assessment of incident exposure (Hanssen et al. 2005).
Another important factor was that one study provided
outcomes based on hospital admission (Werbeloff et al.
2012), whereas all other studies were independent of
health-care use.
Results for dichotomous exposure meta-analysis
Original study results
Findings from individual studies are summarized in
Tables 1b (psychotic outcomes) and 1c (non-psychotic
outcomes).
All studies showed that subclinical psychotic
experiences strongly predicted clinical psychotic out-
comes. The 3- to 24-year risk for the exposed was in
the range 5–25%, substantially higher than the corre-
sponding risk in the non-exposed (ranging from 0.1%
to 3.7%), with 3- to 24-year odds ratios (ORs) in excess
of 10 for the strongest level of exposure (Table 1b). The
ORs for non-psychotic outcomes were weaker, mostly
of the order of 2 (Table 1c).
Meta-analysis
To facilitate comparison, rates for all studies were
uniformly transformed to express incidence of
psychotic and non-psychotic outcomes per 100 000
person-years (Fig. 1a, 1b). This confirmed the pattern
of results in Tables 1b and 1c, in that the incidence of
psychotic clinical outcome in the exposed was much
higher than in the non-exposed, and that the difference
in incidence between exposed and non-exposed was
much greater for psychotic than for non-psychotic
clinical outcome. In addition, the results showed that
the absolute risk for clinical outcome in the only study
based on hospital admission (Werbeloff et al. 2012)
was only a fraction of the risk in studies that did not
depend on service use.
Meta-analysis results for psychotic (Fig. 2a) and
non-psychotic (Fig. 2b) clinical outcomes [for the
Hanssen et al. (2005) study, based on NEMESIS data,
results with prevalence exposure were included] show
that the combined yearly incidence rate of psychotic
clinical outcome, given the presence of a prevalent
subclinical psychotic experience, was 159 per 100 000
person-years (0.2% per year) in the non-exposed and
558 per 100 000 person-years (0.6% per year) in the
exposed. For the non-psychotic outcomes, yearly
transition incidence rates for exposed and non-
exposed were 1.8% and 2.6% respectively. For non-
psychotic outcomes, CIs were wide and for both psy-
chotic and non-psychotic outcomes, CIs overlap
(Fig. 2a, b), indicating that the difference in yearly
incidence rate between exposed and non-exposed was
non-significant for both psychotic and non-psychotic
clinical outcome. Heterogeneity was large (psychotic
outcomes non-exposed: x2=81.6, df=5, p<0.001;
psychotic outcomes exposed: x2=54.1, df=5,
p<0.001 ; non-psychotic outcomes non-exposed: x2=
666.9, df=4, p<0.001; non-psychotic outcomes ex-
posed: x2=235.4, df=4, p<0.001).
Planned sensitivity analysis
Excluding the student-based and hospital-based
studies (Chapman et al. 1994 ; Werbeloff et al.
2012), focusing on the four studies that used similar
CIDI-based methodology for exposure and outcome
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assessment (Poulton et al. 2000 ; Hanssen et al. 2005 ;
Welham et al. 2009 ; Dominguez et al. 2010) revealed
transition rates of psychotic outcomes in exposed and
non-exposed of 0.2% (95% CI 0.09–0.37) and 1.0%
(95% CI 0.38–1.6) respectively, with non-overlapping
CIs. For psychotic outcomes, these rates were 2.8%
(95% CI 2.3–3.4) and 2.2% (95% CI 1.3–3.1) respect-
ively.
Meta-regression, including the four studies that
used similar CIDI-based methodology for exposure
and outcome assessment (Poulton et al. 2000 ; Hanssen
et al. 2005 ; Welham et al. 2009 ; Dominguez et al.
2010), suggested that the effect of subclinical self-
reported psychotic experiences on psychotic clinical
outcome was significant (difference in incidence
between exposed and non-exposed 648 per 100 000
person-years, p=0.043), whereas the effect for non-
psychotic clinical outcome was not statistically sig-
nificant (difference in incidence 694 per 100 000 years,
p=0.31). Meta-regression using permutations showed
similar or more conservative p values (non-psychotic
outcomes exposure p=0.52 ; psychotic outcomes
exposure p=0.11 ; t values were all in the same di-
rection).
Results of the dose–response meta-analysis
Original study results
Where examined, studies reported clear dose–
response relationships for variably defined levels of
exposure severity (certainty of symptom, frequency
of symptom, number of symptoms, persistence
over time, co-morbid depression) in relation to risk
of transition to psychotic clinical outcome (Tables 1a
and 1b). Only weak evidence for dose–response was
present for non-psychotic clinical outcome (Tables 1a
and 1c).
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Meta-analysis
Transformation of all studies to the same person-year
denominator showed comparable dose–response
effects for psychotic clinical outcome, and also for the
study reporting hospital-based outcomes (Werbeloff
et al. 2012) and incident exposure assessment (Hanssen
et al. 2005). Thus, the bars in Fig. 3 show that rates
increase when exposure severity increases. Meta-
regression including the three CIDI-based studies
with linear multiple categories of exposure (Poulton
et al. 2000 ; Hanssen et al. 2005 ; Dominguez et al. 2010)
showed a statistically significant linear increase in
yearly incidence of psychotic outcomes per unit
increase in exposure severity (b=962, p=0.02).
Permutation analysis of this result was also significant
(p=0.03).
Discussion
Subjects with a history of subclinical psychotic ex-
periences displayed higher yearly rates of psychotic
clinical outcome, as evidenced particularly by signifi-
cant meta-analytic dose–response effects. The analyses
suggest a degree of specificity, indicating increased
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transition for psychotic but not for non-psychotic
outcomes, which was evident particularly in the
sensitivity analysis of similar CIDI-based studies.
However, this may reflect low statistical power as
there were suggestive, albeit attenuated, differences
between exposed and non-exposed in the transition
to non-psychotic outcomes too (2.6% versus 1.8%
respectively). In addition, individuals with transition
to psychotic outcomes may have presented with un-
measured affective outcomes earlier in the trajectory.
There was meta-analytic evidence for dose–response
associated with number, certainty, frequency, persist-
ence and level of affective co-morbidity of psychotic
experiences. Furthermore, subsequent analyses in
some of the individual studies presented here have
also shown the importance of motivational impair-
ment (Dominguez et al. 2010) and social dysfunction
(Werbeloff et al. 2012). Follow-up of these findings of
individual studies is needed in future meta-analytic
work when new studies are available.
In combination, these studies provide strong
evidence for the validity of the notion that even self-
reported subclinical psychotic experiences represent
psychometric risk for later psychotic clinical outcome.
Although it could be argued that CIDI measures of
clinical outcome yield high rates of false positives, the
predictive value of subclinical psychotic experiences
was also apparent in predicting the ‘hard’ outcome of
hospital admission. Additional validity is suggested
by the presence of dose–response.
All studies in the meta-analysis assessed self-
reports of psychotic experiences, precluding a com-
parison of transition rates as a function of mode of
assessment. Self-reports of psychotic experiences gen-
erate false-positive ratings. Depending on how data
are analysed, the rate of false-positive self-reported
psychotic experiences when verified by clinical inter-
view may vary from 7% (van Os et al. 2001) to 61%
(Kelleher et al. 2009). In the study by van Os et al.
(2001), lay interviewer CIDI ratings of adult partici-
pants were compared with clinicians’ ratings after
telephone interviews. In the study by Kelleher et al.
(2009), clinicians’ ratings were compared to self-report
questionnaires filled out by adolescent participants.
There is evidence, however, that ‘ false positive ’ in this
context does not indicate absence of risk. Thus, Bak
et al. (2003) found that ‘ false positive ’ psychotic ex-
periences (i.e. the presence of CIDI self-reports of
psychotic experiences that were not confirmed by
clinical interview) nevertheless were strongly asso-
ciated with future psychotic disorder, albeit at a lower
level than self-reported psychotic experiences con-
firmed by clinical interview. These findings echo those
by Poulton et al. (2000), who showed that both ‘defi-
nite ’ and ‘ likely’ psychotic symptoms predicted later
clinical outcomes, and suggest that self-reported psy-
chotic experiences do not come as either ‘ true ’ or
‘ false ’ positive. Instead, they may index risk as a con-
tinuum reflecting the level of certainty (Poulton et al.
2000) as to what degree the experience of aberrant
attribution of salience (Kapur, 2003) that an individual
reports can be regarded as ‘psychotic ’. A recent study
that specifically compared self-report with interview-
based assessment of psychotic experiences in a large
general population sample (n=6646) suggested that
self-reported psychotic experiences not confirmed by
clinical interview may indeed represent the softest
expression of an extended phenotype of aberrant
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attribution of salience that is phenotypically continu-
ous with clinical psychosis, but discontinuous in need
for care (van Nierop et al. 2011).
Methodological issues
A comparison with the high-risk literature is not
possible, as studies in this area follow selected
samples of help-seeking subjects with psychotic ex-
periences that are not population based, are assessed
with different instruments, and use a range of
sample enrichment strategies to boost the risk of
transition. Nevertheless, the base rate of transition as
analysed in this study may serve as a standard against
which risk-enriched ultra-high-risk studies are con-
ducted.
Many of the studies have not followed their samples
through the age of peak risk for development of
psychotic disorders. In addition, in calculating yearly
incidence rates, the assumption was that the rate of
transition would be spread evenly over the follow-up
periods. This may not be valid, as there is some
evidence that transition rates may be higher in the first
5–10 years (Werbeloff et al. 2012). Therefore, yearly
incidence rates in two studies with longer follow-ups
(Poulton et al. 2000 ; Welham et al. 2009) may vary
and be somewhat higher in the earlier phases of the
follow-up. Similarly, rates may vary according to age
and sex, factors that could not be taken into account.
Nevertheless, most studies were carried out in young
people.
Because the present analysis included only six
studies and the analyses focused on rates rather than
ORs, funnel plots are difficult to interpret. Publication
bias cannot be ruled out, as the small number of
studies precluded formally testing this.
Permutation methods within meta-regression
have been developed and implemented in Stata
(StataCorp, 2009). Permutation is necessary because
meta-regression gives increased rates of false positives
when the number of studies is small and when het-
erogeneity is present (Higgins & Thompson, 2004). In
addition, in the present study the outcomes, which are
rates, are not normally distributed, another reason
to conduct permutations. As expected, p values were
more conservative after permutations, but because
results were similar, original coefficients and p values
were presented.
The number of studies included in the meta-
analysis was small and statistical power low,
resulting in inconclusive findings in the more con-
servative permutation analysis. Nevertheless, meta-
analytic evidence of dose–response remained
statistically significant even in the permutation
analysis.
Conclusions
Subthreshold self-reported psychotic experiences in
epidemiological non-help-seeking samples index
psychometric risk for psychotic disorder, with strong
modifier effects of severity/persistence. The yearly
transition rates are low and can serve as the popu-
lation reference for selected and variable samples of
help-seeking individuals at ultra-high risk, for whom
much higher transition rates have been indicated.
Acknowledgements
This project was supported by the Netherlands
Organization for Scientific Research (NWO) under
project number 017.002.048. Dr Köhler was supported
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